ArticleCureus2026
Flagellate Erythema Induced by a Low Cumulative Dose of Bleomycin: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flagellate erythema is a rare, distinctive dermatitis that may be the result of treatment with bleomycin or ingestion of shiitake mushrooms. It has also been associated with conditions such as systemic-onset juvenile idiopathic arthritis (Still disease) or dermatomyositis. We present a case of bleomycin-induced flagellate erythema that occurred at a cumulative dosing of 30 mg, which is less than what typically precipitates onset. Bleomycin-associated flagellate erythema is thought to occur due to the low levels of bleomycin hydrolase (BMH) in the skin. This condition is typically self-limiting, with the mainstays of treatment focusing on control of associated pruritus. In this case, improvement was observed at the two-month follow-up, with resolution of pruritus and characteristic progression to hyperpigmentation, which showed areas of fading at four months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.